GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million

4 weeks ago 23
Under the deal, Alfasigma volition summation rights to develop, manufacture and commercialize linerixibat.
Read Entire Article
  1. Homepage
  2. Health
  3. GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million

Related

Researchers look into island's health benefits

Researchers look into island's health benefits

4 hours ago 2
'Doctors thought my endometriosis was IBS'

'Doctors thought my endometriosis was IBS'

4 hours ago 1
Strike reduces A&E unit to minor injuries service

Strike reduces A&E unit to minor injuries service

15 hours ago 4

Popular

50 Artists Travel Far and Wide to Learn From Filmmaker Werner Herzog

50 Artists Travel Far and Wide to Learn From Filmmaker Werne...

4 days ago 18
Plan to bring more beavers back takes step forward

Plan to bring more beavers back takes step forward

4 days ago 18
United to Offer No-Frills Fares in Its Premium Cabins

United to Offer No-Frills Fares in Its Premium Cabins

4 days ago 17
Would You Let AI Day Trade Your Money?

Would You Let AI Day Trade Your Money?

4 days ago 16
The GOATs reunite: Ronaldo and Messi join forces again for viral LEGO World Cup campaign

The GOATs reunite: Ronaldo and Messi join forces again for v...

4 days ago 13
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved